IRADIMED Corporation (NASDAQ: IRMD) reported third-quarter 2026 revenue of $24.2 million, up 14% from $21.2 million a year earlier. GAAP net income was $6.5 million, while GAAP diluted earnings per share was $0.51.
The company declared a regular quarterly cash dividend of $0.20 per share, payable November 27, 2026, to stockholders of record as of November 13, 2026.
- Third-quarter revenue was $24.203 million, compared with $21.202 million in the prior-year period.
- Net income totaled $6.506 million, versus $5.576 million a year earlier.
- Third-quarter GAAP basic and diluted EPS were both $0.51.
- Nine-month revenue was $66.648 million and net income was $17.542 million.
- Fourth-quarter revenue guidance is $25.0 million to $26.5 million, with GAAP diluted EPS guidance of $0.53 to $0.57.
- Full-year 2026 revenue guidance is $91.6 million to $93.1 million.
$IRMD Insider Trading Activity
$IRMD insiders have traded $IRMD stock on the open market 30 times in the past 6 months. Of those trades, 0 have been purchases and 30 have been sales.
Here’s a breakdown of recent trading of $IRMD stock by insiders over the last 6 months:
- ROGER E. SUSI (CEO, President, Chairman) has made 0 purchases and 26 sales selling 32,500 shares for an estimated $2,849,018.
- HILDA FREDERIQUE SCHAREN-GUIVEL has made 0 purchases and 2 sales selling 3,000 shares for an estimated $285,000.
- MONTY K ALLEN has made 0 purchases and 2 sales selling 1,419 shares for an estimated $122,621.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$IRMD Hedge Fund Activity
We have seen 109 institutional investors add shares of $IRMD stock to their portfolio, and 90 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 263,041 shares (+472.8%) to their portfolio in Q2 2026, for an estimated $25,136,197
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 128,524 shares (+832.1%) to their portfolio in Q2 2026, for an estimated $12,281,753
- ROYAL BANK OF CANADA added 118,371 shares (+397.1%) to their portfolio in Q2 2026, for an estimated $11,311,532
- FIRST TRUST ADVISORS LP added 81,977 shares (+3501.8%) to their portfolio in Q2 2026, for an estimated $7,833,722
- NINE TEN CAPITAL MANAGEMENT LLC removed 77,926 shares (-23.3%) from their portfolio in Q2 2026, for an estimated $7,446,608
- QUBE RESEARCH & TECHNOLOGIES LTD added 73,750 shares (+88.4%) to their portfolio in Q2 2026, for an estimated $7,047,550
- GRANAHAN INVESTMENT MANAGEMENT, LLC added 70,074 shares (+1432.4%) to their portfolio in Q2 2026, for an estimated $6,696,271
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
